Why the study?
Does metoprolol improve cardiac dysfunction and subcellular alterations in rats with heart failure due to myocardial infarction?
Does metoprolol improve cardiac dysfunction and subcellular alterations in rats with heart failure due to myocardial infarction?
Metoprolol partially reverses cardiac dysfunction and subcellular alterations in advanced stages of heart failure in a rat model of myocardial infarction, likely through partial reversal of SR Ca(2+)-pump function and reduction in plasma catecholamines.
Answers are grounded in this paper and cite their sources.
Offers preclinical support for metoprolol in post-MI HF; leaves open translation to human therapy.
In order to examine the reversibility of heart failure due to myocardial infarction (MI) by β-adrenoceptor blockade, 12 weeks infarcted rats were treated with or without metoprolol (50 mg/kg/day) for 8 weeks. The depressed left ventricular (LV) systolic pressure, positive and negative rates of changes in pressure development, ejection fraction, fractional shortening and cardiac output, as well as increased LV end-diastolic pressure in 20 weeks MI animals were partially reversed by metoprolol. MI-induced decreases in septum (systolic) thickness as well as increase in LV posterior wall thickness and LV internal diameter were partially or fully reversible by metoprolol. Treatment of MI animals with metoprolol partially reversed the elevated levels of plasma norepinephrine and dopamine without affecting the elevated levels of epinephrine. Although sarcoplasmic reticular (SR) Ca(2+)-uptake, as well as protein content for SR Ca(2+)-pump and phospholamban, were reduced in the infarcted hearts; these changes were partially reversible with metoprolol. Depressed myofibrillar Ca(2+)-stimulated ATPase activity, as well as mRNA levels for SR Ca(2+)-pump, phospholamban and α-myosin heavy chain, were unaffected whereas increased mRNA level for β-myosin heavy chain was partially reversed by metoprolol. The results suggest that partial improvement of cardiac performance by β-adrenoceptor blockade at advanced stages of heart failure may be due to partial reversal of changes in SR Ca(2+)-pump function whereas partial to complete reverse cardiac remodeling may be due to partial reduction in the elevated levels of plasma catecholamines.
No takes yet. Share an insight, caveat, or question.
Babick et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: